Psychopharmacologic Drugs Advisory Committee; Amendment of Notice

Özet

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Psychopharmacologic Drugs Advisory Committee. This meeting was announced in the Federal Register of August 26, 1999 (64 FR 46687). The amendment is being made to cancel the entire session on October 7, 1999. This meeting will be open to the public. There are no other changes.